NEET PG, NEET MDS admissions 2023: DME Gujarat notifies on Conversion Of Seats After Round 2, details

Published On 2023-08-17 03:30 GMT   |   Update On 2023-08-17 03:30 GMT

Gujarat: The Director of Medical Education (DME Gujarat) has issued important instructions regarding the conversion of seats after the 2nd Round (MD/MS/DIPLOMA/MDS courses).

After giving allotment to all reserved category candidates to reserved seats, reserved category seats are transferable to unreserved category seats. This process will be done at the time of allotment of the 2nd Round. E.g., from NRI quota to Management quota and from SC, ST, SEBC, EWS to General (Open) category, from PwD Quota to respective category, In service quota to the respective category, stated DME on its official website.

Also Read:NEET Admission 2023: DME Gujarat Announces Revised Round 1 Allotment, Reporting Process

Recently DME announced the result of 1st round of seat allotment for NEET PG and NEET MDS admission. The last rank, tentative vacancy after round 1, and details related to admission confirmation have also been released. The result includes STUDENT NAME, MERITNO, Cat Merit, MERIT MARKS, ADM Cat, Adm Seat Type, AIQ Rank, Adm Type, Adm Round, College, and Branch.

Advertisement

The candidates can do online payments OR payment of tuition fees at the designated branch of Axis Bank up to 17/08/2023 (03:30 pm). Reporting at the help center can be done up to 18/08/2023 (04:00 pm). The candidate has to take an appointment at the nearest help center. After taking an appointment, Candidate can download his allotment letter and fees challan from his account after login with the help of User ID & Password.

To view the notice, click on the link below –

https://www.medadmgujarat.org/pg/home.aspx 

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News